Literature DB >> 34994813

Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review.

Döndü Üsküdar Cansu1, Güven Barış Cansu2, Reşit Yildirim3, Mustafa Dinler4, Emel Tekin5, İlknur Ak Sivrikoz6, Cengiz Korkmaz3.   

Abstract

Immunoglobulin (Ig) G4-related disease (IgG4RD) is a chronic autoimmune disorder characterized by dense lymphoplasmacytic infiltrations and fibrosis of storiform pattern. The most typical manifestations include major salivary or lacrimal gland involvement, autoimmune pancreatitis, and retroperitoneal fibrosis. While the increase in IgG4 is the typical feature of the disease, hypercalcemia has been rarely reported in IgG4RD so far, only one of these cases has been shown parathyroid gland involvement (isolated involvement). In this study, we present a 43-year-old female patient with weight loss, pancreatic mass, lymphadenopathy, nodular lesion in the lung, hypercalcemia, and also increased level of serum IgG4. Histopathological investigation following parathyroidectomy revealed a dense lymphoplasmacytic infiltrate with an IgG4 to IgG ratio of > 50% in the fat tissue surrounding the parathyroid gland, particularly at the perivascular areas. This is the first systemic IgG4RD case in combination with hypercalcemia in the literature who was detected to have parathyroid adenoma. Our aim in this review is to emphasize that, although rarely, IgG4RD may be accompanied by hypercalcemia and parathyroid gland may be one of its target sites.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Hypercalcemia; Hyperparathyroidism; IgG4-related disease; Parathyroid adenoma

Mesh:

Substances:

Year:  2022        PMID: 34994813     DOI: 10.1007/s00296-021-05076-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  2 in total

Review 1.  Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review.

Authors:  Alvaro Sanabria; Pilar Pinillos; Renan B Lira; Jatin P Shah; Ralph P Tufano; Mark E Zafereo; Iain J Nixon; Gregory W Randolph; Ricard Simo; Vincent Vander Poorten; Alessandra Rinaldo; Jesus E Medina; Avi Khafif; Peter Angelos; Antti A Mäkitie; Ashok R Shaha; Juan P Rodrigo; Dana M Hartl; Luiz P Kowalski; Alfio Ferlito
Journal:  Head Neck       Date:  2021-09-30       Impact factor: 3.147

2.  Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?

Authors:  A Catalano; D Chilà; F Bellone; G Nicocia; G Martino; I Loddo; N Morabito; S Benvenga; S Loddo
Journal:  J Clin Transl Endocrinol       Date:  2018-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.